Seven Fleet Capital Management’s Damora Therapeutics DMRA Stock Holding History
Bought
Maintained
Sold
Other funds holding DMRA
Seven Fleet Capital Management's DMRA Position: Q3 2026 in Review
Seven Fleet Capital Management increased its Damora Therapeutics (DMRA) stake by 1.4% in Q3 2026, buying an estimated $113K and bringing the position to 288,439 shares worth $6.14M. The position accounts for 1.2% of the portfolio, ranked #16.
Seven Fleet Capital Management first reported a position in DMRA in Q1 2026 and has held it in 3 quarters since. The position peaked at $7.4M in Q2 2026. 115 funds tracked by Wall St. Rank hold DMRA as of Q3 2026.
- Seven Fleet Capital Management held 288,439 shares of Damora Therapeutics worth $6.14M as of Q3 2026.
- Seven Fleet Capital Management bought 4,009 Damora Therapeutics shares in Q3 2026, an estimated $113K.
- Damora Therapeutics made up 1.2% of Seven Fleet Capital Management's portfolio in Q3 2026, its #16 holding.
- Seven Fleet Capital Management first reported a position in Damora Therapeutics in Q1 2026 and has held it in 3 quarters since.
- Seven Fleet Capital Management's Damora Therapeutics position peaked at $7.4M in Q2 2026.
- 115 funds tracked by Wall St. Rank held Damora Therapeutics as of Q3 2026.
Based on Seven Fleet Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.